Loading...
AAV gene therapy for cystic fibrosis: current barriers and recent developments
INTRODUCTION: Since the CF gene was discovered in 1989, researchers have worked to develop a gene therapy. One of the most promising and enduring vectors is AAV, which has been shown to be safe. In particular, several clinical trials have been conducted with AAV serotype 2. All of them detected vira...
Na minha lista:
| Udgivet i: | Expert Opin Biol Ther |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5858933/ https://ncbi.nlm.nih.gov/pubmed/28657358 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14712598.2017.1347630 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|